BD IMag- Anti-Human CD19 Magnetic Particles - DM_BD Pharmingen
参考图片
Positive selection and depletion of human CD19-positive PBMC. Leukocytes were labeled with BD IMag™ anti-human CD19 Particles - DM (Cat. No. 551520) as described in the protocol. After labeling, the cells were separated using the BD IMag™ Cell Separation Magnet (Cat. No. 552311), and the negative (CD19-) and positive (CD19+) fractions were collected. Please refer to the Separation Flow Chart to identify the separated cell populations represented in this figure. For flow cytometric analysis, fresh PBMC (left panel), the negative fraction (middle panel) and the positive fraction (right panel) were stained with PE Mouse Anti-Human CD19 (Cat. No. 555413) and APC Mouse Anti-Human CD3 (Cat. No. 555335). The percent CD19+ cells in each sample is given.
Positive selection and depletion of human CD19-positive PBMC. Leukocytes were labeled with BD IMag™ anti-human CD19 Particles - DM (Cat. No. 551520) as described in the protocol. After labeling, the cells were separated using the BD IMag™ Cell Separation Magnet (Cat. No. 552311), and the negative (CD19-) and positive (CD19+) fractions were collected. Please refer to the Separation Flow Chart to identify the separated cell populations represented in this figure. For flow cytometric analysis, fresh PBMC (left panel), the negative fraction (middle panel) and the positive fraction (right panel) were stained with PE Mouse Anti-Human CD19 (Cat. No. 555413) and APC Mouse Anti-Human CD3 (Cat. No. 555335). The percent CD19+ cells in each sample is given.
本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/kangti/8981.html